Dermelle
Columbia, US · Founded 2009
Founders & leadership
SA
Sheila Ann GrantChief Technology Officer
CW
Charles WeatherstoneChief Commercialization Officer
AM
Anna Magdalena LundvallChairman of the Board, Chief Executive Officer
DP
Dale Paul DeVoreChief Science Officer
LR
Luis Raul JimenezPresident, Chief Operating Officer, Manager
RJ
Rebecca Jane Rone-McCrateDirector of Clinical and Regulatory Affairs, Manager
DA
David Alan GrantManager, Director of Analytical Development
AN
Anthony Nathaniel HarrisManager
RJ
Robert J BrooksDirector of Quality
Board
DB
David Burton KellerManager
GF
Guy Francois BouchardManager
Reported raises · per SEC filings
Form D private placements$2M disclosed across 1 round · 2013
▶$2MraisedNov 2014 · 28 investors · BiotechnologyRule 506(b)
▶$2MraisedNov 2014 · 28 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David Alan GrantDirector
- Anthony Nathaniel HarrisDirector
- David Burton KellerDirector
- Sheila Ann GrantExecutive Officer
- Charles WeatherstoneDirector
- Anna Magdalena LundvallExecutive Officer, Director
- Robert J BrooksDirector
- Dale Paul DeVoreExecutive Officer
- Luis Raul JimenezExecutive Officer, Director
- Guy Francois BouchardDirector
- Rebecca Jane Rone-McCrateDirector
- Offering amount
- $2M
- Amount sold
- $2M
- Minimum investment
- $5K
- Proceeds to insiders
- $755.7K
- Placement agents
- Michael Donnelly Samouce
- First sale
- May 2013
- Incorporated
- Limited Liability Company, Missouri, 2009
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Dermelle raised?
- Dermelle has disclosed $2M raised across 1 round.
- Where is Dermelle headquartered?
- Dermelle is headquartered in Columbia, US.